Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

Recruiting now

Conditions studied: Lung Cancer

In brief

The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main questions it aims to answer are: * What is the best surgical strategy for patients with early-stage lung cancer? * What are the risk factors for early-stage lung cancer? Participants will receive surgery and the study will analyze the real-world data.

Key facts

Study ID

NCT06483698

Run by

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

People needed

20000

Starts

2024-03-01

Expected to finish

2034-12-01

Last updated by the study team

2025-08-29

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged between 18 and 85;
• Did not receive neoadjuvant therapy before surgery;
• No history of radiation therapy;
• Eastern Cooperative Oncology Group (ECOG) score is 0-1;
• Have complete clinically relevant information including imaging data;
• All patients underwent relevant preoperative examinations;
• Stage I lung cancer (International Association for the Study of Lung Cancer/The Union for International Cancer Control staging eighth edition);

You may not qualify if…

• Have previously received chemotherapy, radiotherapy and other anti-tumor therapy;
• Data loss and error in medical records due to human/objective reasons.

Where it is running

• Shugeng Gao — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.